CLINICAL_TRIALS
trial_result
· 2022-02-22
Clinical Trial Update: Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging [Phase 2]
Summary
Phase 2 trial update on non-invasive diagnosis of pulmonary vascular disease using inhaled 129Xe MRI; results completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Bastiaan Driehuys | Conditions: Pulmonary Vascular Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-02-22